Aclaris Therapeutics (NASDAQ:ACRS – Get Free Report) released its quarterly earnings data on Thursday. Aclaris Therapeutics Price PerformanceAclaris Therapeutics stock opened at $5.91 on Friday. Aclaris Therapeutics has a 1 year low of $1.57 and a 1 year high of $6.51. UBS Group set a $10.00 price objective on Aclaris Therapeutics in a research report on Thursday, April 16th. Featured StoriesReceive News & Ratings for Aclaris Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclaris Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.